AMEX:MLSS

Stock Analysis Report

Executive Summary

Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally.

Snowflake

Fundamentals

Excellent balance sheet with limited growth.

Risks

  • Milestone Scientific has significant price volatility in the past 3 months.
  • Milestone Scientific is covered by less than 3 analysts.

Share Price & News

How has Milestone Scientific's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

9.8%

AMEX:MLSS

0.5%

US Medical Equipment

-0.02%

US Market


1 Year Return

7.0%

AMEX:MLSS

9.9%

US Medical Equipment

1.6%

US Market

MLSS underperformed the Medical Equipment industry which returned 9.7% over the past year.

MLSS outperformed the Market in United States of America which returned 1.9% over the past year.


Share holder returns

MLSSIndustryMarket
7 Day9.8%0.5%-0.02%
30 Day32.2%0.09%2.7%
90 Day141.5%2.0%1.4%
1 Year7.0%7.0%10.8%9.9%3.8%1.6%
3 Year-60.5%-60.5%69.0%63.9%45.2%35.8%
5 Year-59.5%-59.5%136.2%109.3%61.8%44.1%

Price Volatility Vs. Market

How volatile is Milestone Scientific's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Milestone Scientific undervalued based on future cash flows and its price relative to the stock market?

44.83x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for Milestone Scientific to establish if it is available at moderate discount.

Unable to calculate intrinsic value for Milestone Scientific to establish if it is available at substantial discount.


Price Based on Earnings

Milestone Scientific is loss making, we can't compare its value to the US Medical Equipment industry average.

Milestone Scientific is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Milestone Scientific, we can't assess if its growth is good value.


Price Based on Value of Assets

Milestone Scientific is overvalued based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Milestone Scientific expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

87.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Milestone Scientific's revenue is expected to grow significantly at over 20% yearly.

Milestone Scientific is not considered high growth as it is expected to be loss making for the next 1-3 years.

Milestone Scientific's revenue growth is expected to exceed the United States of America market average.

Unable to compare Milestone Scientific's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.

Unable to compare Milestone Scientific's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Milestone Scientific will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Milestone Scientific performed over the past 5 years?

-25.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Milestone Scientific does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Milestone Scientific's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Milestone Scientific's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Milestone Scientific has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Milestone Scientific has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Milestone Scientific improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Milestone Scientific's financial position?


Financial Position Analysis

Milestone Scientific is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Milestone Scientific has no long term commitments.


Debt to Equity History and Analysis

Milestone Scientific's level of debt (-1.9%) compared to net worth is satisfactory (less than 40%).

Unable to establish if Milestone Scientific's debt level has increased without past 5-year debt data.


Balance Sheet

Low level of unsold assets.

Debt is not covered by short term assets, assets are -395.4x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Milestone Scientific has sufficient cash runway for more than 3 years based on current free cash flow.

Milestone Scientific has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of -48.8% each year.


Next Steps

Dividend

What is Milestone Scientific's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Milestone Scientific's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Milestone Scientific's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Milestone Scientific has not reported any payouts.

Unable to verify if Milestone Scientific's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Milestone Scientific has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Milestone Scientific's salary, the management and board of directors tenure and is there insider trading?

2.9yrs

Average management tenure


CEO

Leonard Osser (72yo)

1.8yrs

Tenure

US$540,484

Compensation

Mr. Leonard A. Osser has been the Interim Chief Executive Officer of Milestone Scientific Inc., since December 18, 2017. Mr. Osser is a Founder of Milestone Scientific Inc. and had been Managing Director o ...


CEO Compensation Analysis

Leonard's remuneration is about average for companies of similar size in United States of America.

Leonard's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

2.9yrs

Average Tenure

59yo

Average Age

The tenure for the Milestone Scientific management team is about average.


Board Age and Tenure

4.6yrs

Average Tenure

72yo

Average Age

The tenure for the Milestone Scientific board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyUS$29,75026 Feb 19
Michael McGeehan
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares85,000
Max PriceUS$0.35
BuyUS$250,00026 Feb 19
Innovest SpA
EntityCompany
Shares714,286
Max PriceUS$0.35
BuyUS$99,75008 Feb 19
Leonard Osser
EntityIndividual
Role
Chief Executive Officer
Founder
Shares285,000
Max PriceUS$0.35
BuyUS$5,25008 Feb 19
Edward Zelnick
EntityIndividual
Role
Member of the Board of Directors
Independent Director
Shares15,000
Max PriceUS$0.35

Ownership Breakdown


Management Team

  • Leonard Osser (72yo)

    Founder

    • Tenure: 1.8yrs
    • Compensation: US$540.48k
  • Rosaline Shau (59yo)

    Vice President and Assistant Controller

    • Tenure: 0yrs
  • Sharon Smith

    Executive Vice President of Global Sales & Marketing

    • Tenure: 1.5yrs
    • Compensation: US$284.04k
  • Joseph D'Agostino (67yo)

    CFO & COO

    • Tenure: 11.7yrs
    • Compensation: US$225.30k
  • Brent Johnston (50yo)

    President

    • Tenure: 0yrs
  • Gian Trombetta (58yo)

    President & CEO of Wand Dental Inc. and Director

    • Tenure: 5.3yrs
    • Compensation: US$280.00k
  • James McAvinn

    Senior Vice President of Sales & Marketing

    • Tenure: 2.9yrs

Board Members

  • Leslie Bernhard (75yo)

    Chairman of the Board

    • Tenure: 9.9yrs
    • Compensation: US$66.00k
  • Leonard Osser (72yo)

    Founder

    • Tenure: 1.8yrs
    • Compensation: US$540.48k
  • Neal Goldman (75yo)

    Director

    • Tenure: 0.4yrs
  • Leonard Schiller (78yo)

    Independent Director

    • Tenure: 22.4yrs
    • Compensation: US$36.00k
  • Zhang Lidong (58yo)

    Member of Global Advisory Board

    • Tenure: 3.5yrs
  • Joe Chalil (46yo)

    Member of Global Advisory Board

    • Tenure: 3.5yrs
  • Edward Zelnick (73yo)

    Independent Director

    • Tenure: 4.6yrs
    • Compensation: US$36.00k
  • Gian Trombetta (58yo)

    President & CEO of Wand Dental Inc. and Director

    • Tenure: 5.3yrs
    • Compensation: US$280.00k
  • Michael McGeehan (53yo)

    Independent Director

    • Tenure: 1.9yrs
    • Compensation: US$36.00k

Company Information

Milestone Scientific Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Milestone Scientific Inc.
  • Ticker: MLSS
  • Exchange: AMEX
  • Founded: 1989
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$39.384m
  • Shares outstanding: 47.49m
  • Website: https://www.milestonescientific.com

Number of Employees


Location

  • Milestone Scientific Inc.
  • 220 South Orange Avenue
  • Livingston
  • New Jersey
  • 7039
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MLSSAMEX (NYSE MKT LLC)YesCommon StockUSUSDNov 1995

Biography

Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates in two segments, Dental ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/18 23:39
End of Day Share Price2019/09/18 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.